Bingsen Zhou

3.6k total citations
70 papers, 3.0k citations indexed

About

Bingsen Zhou is a scholar working on Molecular Biology, Oncology and Inorganic Chemistry. According to data from OpenAlex, Bingsen Zhou has authored 70 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 37 papers in Oncology and 22 papers in Inorganic Chemistry. Recurrent topics in Bingsen Zhou's work include Metal-Catalyzed Oxygenation Mechanisms (22 papers), RNA modifications and cancer (22 papers) and Metal complexes synthesis and properties (17 papers). Bingsen Zhou is often cited by papers focused on Metal-Catalyzed Oxygenation Mechanisms (22 papers), RNA modifications and cancer (22 papers) and Metal complexes synthesis and properties (17 papers). Bingsen Zhou collaborates with scholars based in United States, China and Taiwan. Bingsen Zhou's co-authors include Yun Yen, Xiyong Liu, Jennifer Shih, Jimin Shao, Shuya Hu, Lijun Xue, Peiguo Chu, Erding Hu, Yih-Gang Goan and Lijun Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Bingsen Zhou

68 papers receiving 3.0k citations

Peers

Bingsen Zhou

ONCOL

PRM

Saverio Tardito Italy

Jimin Shao China

Xiyong Liu China

Yate‐Ching Yuan United States

David Heimbrook United States

Jinyun Liu United States

Anthony Tumber United Kingdom

Christine Pirker Austria

Mark R. Bray Canada

Sylvie M. Guichard United Kingdom

Saverio Tardito Italy

Bingsen Zhou

1.6k ×0.7

916 ×0.8

ONCOL

1.0k ×1.4

197 ×0.4

161 ×0.7

PRM

Citations per year, relative to Bingsen Zhou Bingsen Zhou (= 1×) peers Saverio Tardito

Countries citing papers authored by Bingsen Zhou

Since Specialization

Citations

This map shows the geographic impact of Bingsen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingsen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingsen Zhou more than expected).

Fields of papers citing papers by Bingsen Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingsen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingsen Zhou. The network helps show where Bingsen Zhou may publish in the future.

Co-authorship network of co-authors of Bingsen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Bingsen Zhou. A scholar is included among the top collaborators of Bingsen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingsen Zhou. Bingsen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xuchen, et al.. (2025). Cytokine release syndrome complicated with sepsis induced by tislelizumab in a patient with advanced hepatocellular carcinoma: A case report. Human Vaccines & Immunotherapeutics. 21(1). 2597064–2597064.

Chen, Mei-Chuan, Bingsen Zhou, Keqiang Zhang, et al.. (2015). The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro. Molecular Pharmacology. 87(6). 996–1005. 23 indexed citations

Qiu, Yunping, Guoxiang Cai, Bingsen Zhou, et al.. (2014). A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential. Clinical Cancer Research. 20(8). 2136–2146. 142 indexed citations

Chen, Wei, Lisheng Zhang, Keqiang Zhang, et al.. (2014). Reciprocal regulation of autophagy and dNTP pools in human cancer cells. Autophagy. 10(7). 1272–1284. 55 indexed citations

Zhou, Bingsen, Leila Su, Shuya Hu, et al.. (2013). A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance. Cancer Research. 73(21). 6484–6493. 65 indexed citations

Fu, Shibo, Ying Yang, Yun Yen, et al.. (2012). γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers. PLoS ONE. 7(6). e38465–e38465. 25 indexed citations

Liu, Xiyong, Lily Lai, Xiaochen Wang, et al.. (2011). Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer. Cancer Research. 71(9). 3202–3213. 52 indexed citations

Wang, Xiaochen, Xiyong Liu, Lirong Chen, et al.. (2011). Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers. Clinical Cancer Research. 17(8). 2570–2580. 151 indexed citations

Zhang, Keqiang, Jun Wu, Xiwei Wu, et al.. (2011). p53R2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest. Molecular Cancer Therapeutics. 10(2). 269–278. 43 indexed citations

10.

Passer, Brent J., Tooba A. Cheema, Bingsen Zhou, et al.. (2010). Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication. Cancer Research. 70(10). 3890–3895. 26 indexed citations

11.

Jiang, Chunling, Bingsen Zhou, Kenneth L. Fan, et al.. (2008). A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells.. PubMed. 27(6B). 3783–9. 15 indexed citations

12.

Heidel, Jeremy D., Yun Yen, Bingsen Zhou, et al.. (2007). Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation In vitro and In vivo. Clinical Cancer Research. 13(7). 2207–2215. 130 indexed citations

13.

Liu, Xiyong, Bingsen Zhou, Lijun Xue, et al.. (2007). Ribonucleotide Reductase Subunits M2 and p53R2 are Potential Biomarkers for Metastasis of Colon Cancer. Clinical Colorectal Cancer. 6(5). 374–381. 48 indexed citations

14.

Yen, Yun, et al.. (2006). Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase. Advances in Enzyme Regulation. 46(1). 235–247. 4 indexed citations

15.

Shao, Jimin, Bingsen Zhou, Lijun Zhu, et al.. (2005). Characterization of the interacting mechanisms between Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and the small subunits of human Ribonucleotide Reductase. Cancer Research. 65. 969–969. 2 indexed citations

16.

Qiu, Weihua, et al.. (2005). Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits. Biochemical and Biophysical Research Communications. 340(2). 428–434. 18 indexed citations

17.

Shao, Jimin, Bingsen Zhou, Lijun Zhu, et al.. (2005). Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay. Biochemical Pharmacology. 69(4). 627–634. 31 indexed citations

18.

Jong, Ambrose, Kefei Yu, Bingsen Zhou, et al.. (1998). A simple and sensitive ribonucleotide reductase assay. Journal of Biomedical Science. 5(1). 62–68. 14 indexed citations

19.

Chang, Jang‐Yang, et al.. (1992). Characterization of camptothecin-resistant chinese hamster lung cells. Biochemical Pharmacology. 43(11). 2443–2452. 69 indexed citations

20.

Bastow, Kenneth F., Bingsen Zhou, & Yung‐Chi Cheng. (1989). Human topoisomerase 1 messenger RNA is not destabilized by the herpes simplex virus type 2 virion-associated shut-off function. Virus Genes. 2(4). 357–365. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact